EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond

Mirta Mosca, Maria Concetta Nigro iD, Rachele Pagani, Andrea De Giglio iD, Alessandro Di Federico iD

Biomolecules · 18.12.2023 · 13 (12) · 1803

DOI: 10.3390/biom13121803 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 18.12.2023. Verfasst von Mirta Mosca und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, S. Orsola-Malpighi University Hospital, University of Bologna, 40138 Bologna, Italy. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the era of immunotherapy, identifying biomarkers of immune system activation has become a high-priority challenge. The blood neutrophil-to-lymphocyte ratio (NLR) has been largely investigated as a biomarker in several cancer types. NLR values have been shown to mirror the tumor-induced inflammatory status and have been demonstrated to be a reliable prognostic tool across stages of disease and therapeutic approaches. When integrated with other biomarkers of response to immunotherapy, such as PD-L1, tumor mutational burden, and tumor-associated immune cells, the NLR may allow to further stratify patients with different likelihoods of deriving a significant clinical benefit. However, despite its accessibility, low cost, and easy interpretation, the NLR is still poorly used as a prognostic tool in daily clinical practice. In this review, we analyze the role of the NLR in defining the relationship between cancer and the immune system, its usefulness in daily clinical practice, and its relationship with other established or emerging biomarkers of immunotherapy outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansNeutrophilsLymphocytesBiomarkers, TumorImmunotherapy

Stichwörter der Autor:innen

NLRimmunotherapyneutrophil-to-lymphocyte ratioprognosis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, S. Orsola-Malpighi University Hospital, University of Bologna, 40138 Bologna, Italy.
  • Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

ORCID-Profile: Maria Concetta Nigro, Andrea De Giglio, Alessandro Di Federico

Zitieren

APA

Mosca, M., Nigro, M. C., Pagani, R., De Giglio, A., & Di Federico, A. (2023). Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond. Biomolecules, 13(12), 1803. https://doi.org/10.3390/biom13121803

Vancouver

Mosca M, Nigro MC, Pagani R, De Giglio A, Di Federico A. Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond. Biomolecules. 2023;13(12):1803. doi:10.3390/biom13121803

BibTeX
@article{Mosca2023,
  author = {Mosca, Mirta and Nigro, Maria Concetta and Pagani, Rachele and De Giglio, Andrea and Di Federico, Alessandro},
  title = {Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond},
  journal = {Biomolecules},
  year = {2023},
  volume = {13},
  number = {12},
  pages = {1803},
  doi = {10.3390/biom13121803}
}
Kostenlos starten →